AVITA Medical, Inc. Net Change in Cash
AVITA Medical, Inc. (AVHHL) reported Net Change in Cash of -$1.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-06
- AVITA Medical, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was -$1.93M, a 335.85% decline year-over-year.
- AVITA Medical, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $820.00K.
- AVITA Medical, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$5.17M, a 152.27% decline year-over-year.
- AVITA Medical, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $9.89M.
- AVITA Medical, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was -$3.81M.
- AVITA Medical, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$8.07M, a 304.05% decline from fiscal 2023.
- AVITA Medical, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $3.95M.
- AVITA Medical, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$37.55M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.10M 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | -$1.93M 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | -$3.81M 10-K · filed 2026-02-12 | |||
| 2025-09-30 | $1.37M 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | -$1.83M 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | $820.00K 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | -$8.07M 10-K · filed 2026-02-12 | |||
| 2024-09-30 | -$3.48M 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | -$4.67M 10-Q · filed 2025-08-08 | |||
| 2024-03-31 | -$5.17M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $3.95M 10-K · filed 2025-02-13 | |||
| 2023-09-30 | $32.69M 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | $19.32M 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | $9.89M 10-Q · filed 2024-05-13 | |||
| 2022-12-31 | -$37.55M 10-K · filed 2024-02-22 | |||
| 2022-09-30 | -$31.90M 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | -$20.77M 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | -$31.98M 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$55.23M 10-K · filed 2023-02-23 | |||
| 2021-09-30 | -$50.26M 10-Q · filed 2021-11-08 | $719.00K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $50.98M 10-Q · filed 2022-08-11 | $37.11M 10-K · filed 2023-02-23 | ||
| 2021-03-31 | $55.11M 10-Q · filed 2022-05-12 | $41.24M 10-Q · filed 2021-05-13 | ||
| 2020-12-31 | -$13.87M 10-KT · filed 2022-02-28 | |||
| 2020-09-30 | -$7.89M 10-Q · filed 2021-11-08 | |||
| 2020-06-30 | $53.47M 10-KT · filed 2022-02-28 | |||
| 2020-03-31 | $59.39M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $67.09M 10-Q · filed 2021-02-16 | |||
| 2019-09-30 | -$5.07M 10-Q · filed 2020-11-10 | |||
| 2019-06-30 | $9.39M 10-K · filed 2021-08-26 | |||
| 2018-06-30 | $8.07M 10-K · filed 2020-08-27 |